|
WO2008129070A1
(en)
|
2007-04-24 |
2008-10-30 |
Ingenium Pharmaceuticals Gmbh |
Inhibitors of protein kinases
|
|
JP5566879B2
(ja)
*
|
2007-04-24 |
2014-08-06 |
インゲニウム ファーマシューティカルズ ジーエムビーエイチ |
プロテインキナーゼの阻害剤
|
|
US8507498B2
(en)
*
|
2007-04-24 |
2013-08-13 |
Ingenium Pharmaceuticals Gmbh |
4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
|
|
WO2011003236A1
(zh)
|
2009-07-08 |
2011-01-13 |
乔志亚生技股份有限公司 |
一种龙眼核萃取物的制备方法与应用
|
|
JP2013107824A
(ja)
*
|
2010-03-17 |
2013-06-06 |
Dainippon Sumitomo Pharma Co Ltd |
新規単環ピリミジン誘導体
|
|
CN102933561B
(zh)
*
|
2010-03-22 |
2016-05-11 |
利德发现中心有限责任公司 |
具有药学活性的二取代三嗪衍生物
|
|
WO2012066065A1
(en)
*
|
2010-11-17 |
2012-05-24 |
Novartis Ag |
Phenyl-heteroaryl amine compounds and their uses
|
|
WO2012117048A1
(en)
|
2011-03-02 |
2012-09-07 |
Lead Discovery Center Gmbh |
Pharmaceutically active disubstituted triazine derivatives
|
|
JP5947818B2
(ja)
*
|
2011-03-02 |
2016-07-06 |
リード ディスカバリー センター ゲーエムベーハー |
薬学的活性化二置換ピリジン誘導体
|
|
CA2833288A1
(en)
*
|
2011-04-19 |
2012-10-26 |
Bayer Intellectual Property Gmbh |
Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines
|
|
EP2527332A1
(en)
|
2011-05-24 |
2012-11-28 |
Bayer Intellectual Property GmbH |
4-Aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group as CDK9 inhibitors
|
|
TWI555737B
(zh)
|
2011-05-24 |
2016-11-01 |
拜耳知識產權公司 |
含有硫醯亞胺基團之４－芳基－ｎ－苯基－１，３，５－三氮雜苯－２－胺
|
|
EP2755956B1
(en)
*
|
2011-09-16 |
2016-05-18 |
Bayer Intellectual Property GmbH |
2,4-disubstituted 5-fluoro-pyrimidines as selective cdk9 inhibtors
|
|
JP5976814B2
(ja)
*
|
2011-09-16 |
2016-08-24 |
バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ |
スルホキシイミン基を含有する二置換５−フルオロピリミジン誘導体
|
|
CA2888381A1
(en)
|
2012-10-18 |
2014-04-24 |
Bayer Pharma Aktiengesellschaft |
4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfone group
|
|
ES2595222T3
(es)
*
|
2012-10-18 |
2016-12-28 |
Bayer Pharma Aktiengesellschaft |
Derivados de 5-fluoro-N-(piridin-2-il)piridin-2-amina que contienen un grupo sulfona
|
|
CA2888383A1
(en)
*
|
2012-10-18 |
2014-04-24 |
Bayer Pharma Aktiengesellschaft |
N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group
|
|
SG11201503079PA
(en)
|
2012-11-15 |
2015-06-29 |
Bayer Pharma AG |
5-FLUORO-<i>N</i>-(PYRIDIN-2-YL)PYRIDIN-2-AMINE DERIVATIVES CONTAINING A SULFOXIMINE GROUP
|
|
TW201418243A
(zh)
|
2012-11-15 |
2014-05-16 |
Bayer Pharma AG |
含有磺醯亞胺基團之ｎ－（吡啶－２－基）嘧啶－４－胺衍生物
|
|
CA2891244C
(en)
*
|
2012-11-15 |
2020-12-01 |
Ulrich Lucking |
4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine group
|
|
CA2917096C
(en)
|
2013-07-04 |
2021-05-18 |
Bayer Pharma Aktiengesellschaft |
Sulfoximine substituted 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives and their use as cdk9 kinase inhibitors
|
|
CA2942119A1
(en)
|
2014-03-13 |
2015-09-17 |
Bayer Pharma Aktiengesellschaft |
5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
|
|
US9790189B2
(en)
|
2014-04-01 |
2017-10-17 |
Bayer Pharma Aktiengesellschaft |
Disubstituted 5-fluoro pyrimidine derivatives containing a sulfondiimine group
|
|
CN106459084B
(zh)
|
2014-04-11 |
2019-04-19 |
拜耳医药股份有限公司 |
大环化合物
|
|
EP3207037B1
(en)
|
2014-10-16 |
2019-01-23 |
Bayer Pharma Aktiengesellschaft |
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfone group
|
|
CA2964696C
(en)
|
2014-10-16 |
2022-09-06 |
Bayer Pharma Aktiengesellschaft |
Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfoximine group
|
|
WO2016150902A1
(en)
|
2015-03-24 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating gastric cancers
|
|
WO2016150903A1
(en)
|
2015-03-24 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating lymphomas
|
|
WO2016150893A1
(en)
|
2015-03-24 |
2016-09-29 |
Bayer Pharma Aktiengesellschaft |
Use of 4-(4-fluoro-2-methoxyphenyl)-n-{3-[(s-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine for treating multiple myeloma
|
|
DK3539961T3
(da)
|
2015-06-29 |
2022-01-03 |
Astrazeneca Ab |
Polycykliske amidderivativer som cdk9-inhibitorer
|
|
EP3356373B1
(en)
|
2015-09-29 |
2020-02-19 |
Bayer Pharma Aktiengesellschaft |
Novel macrocyclic sulfondiimine compounds
|
|
CN108368129B
(zh)
|
2015-10-08 |
2021-08-17 |
拜耳医药股份有限公司 |
改性大环化合物
|
|
WO2017060322A2
(en)
|
2015-10-10 |
2017-04-13 |
Bayer Pharma Aktiengesellschaft |
Ptefb-inhibitor-adc
|
|
WO2018177889A1
(en)
|
2017-03-28 |
2018-10-04 |
Bayer Aktiengesellschaft |
Novel ptefb inhibiting macrocyclic compounds
|
|
ES2900199T3
(es)
|
2017-03-28 |
2022-03-16 |
Bayer Ag |
Novedosos compuestos macrocíclicos inhibidores de PTEFB
|
|
CN111727183B
(zh)
|
2018-02-13 |
2023-12-29 |
拜耳公司 |
5-氟-4-(4-氟-2-甲氧基苯基)-n-{4-[(s-甲基磺亚胺酰基)甲基]吡啶-2-基}吡啶-2-胺用于治疗弥漫性大b细胞淋巴瘤中的用途
|
|
EP4129293A4
(en)
*
|
2020-03-27 |
2024-04-03 |
Kyoto University |
Nerve cell degeneration inhibitor
|